31. Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States. Issue 12 (13th November 2018) Authors: Park, Jong Chul; Gourin, Christine G.; Kiess, Ana P.; Mehra, Ranee; Forastiere, Arlene A.; Kang, Hyunseok Journal: Head & neck Issue: Volume 40:Issue 12(2018) Page Start: 2612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Pembrolizumab for the treatment of head and neck squamous cell cancer. (2nd September 2019) Authors: Ho, Won Jin; Mehra, Ranee Journal: Expert opinion on biological therapy Issue: Volume 19:Number 9(2019) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Issue 10167 (12th January 2019) Authors: Cohen, Ezra E W; Soulières, Denis; Le Tourneau, Christophe; Dinis, José; Licitra, Lisa; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Zhang, Pingye; Cheng, Jonathan; Swaby, Ramona F; Harrington, Kevin J Journal: Lancet Issue: Volume 393:Issue 10167(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). Issue 2 (10th January 2022) Authors: Ferris, Robert L.; Flamand, Yael; Weinstein, Gregory S.; Li, Shuli; Quon, Harry; Mehra, Ranee; Garcia, Joaquin J.; Chung, Christine H.; Gillison, Maura L.; Duvvuri, Umamaheswar; O'Malley, Bert W.; Ozer, Enver; Thomas, Giovana R.; Koch, Wayne M.; Gross, Neil D.; Bell, R. Bryan; Saba, Nabil F.; Lan... Journal: Journal of clinical oncology Issue: Volume 40:Issue 2(2022) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Issue 11 (November 2015) Authors: Murphy, Colin T.; Devarajan, Karthik; Wang, Lora S.; Mehra, Ranee; Ridge, John A.; Fundakowski, Christopher; Galloway, Thomas J. Journal: Oral oncology Issue: Volume 51:Issue 11(2015:Nov.) Page Start: 1034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Issue 11 (November 2015) Authors: Murphy, Colin T.; Devarajan, Karthik; Wang, Lora S.; Mehra, Ranee; Ridge, John A.; Fundakowski, Christopher; Galloway, Thomas J. Journal: Oral oncology Issue: Volume 51:Issue 11(2015:Nov.) Page Start: 1034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma. (April 2019) Authors: Eze, Nnamdi; Lee, Ju-Whei; Yang, Dong-Hua; Zhu, Fang; Neumeister, Veronique; Sandoval-Schaefer, Teresa; Mehra, Ranee; Ridge, John A.; Forastiere, Arlene; Chung, Christine H.; Burtness, Barbara Journal: Oral oncology Issue: Volume 91(2019) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. (14th May 2020) Authors: Harrington, Kevin J; Soulières, Denis; Le Tourneau, Christophe; Dinis, Jose; Licitra, Lisa F; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal H; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Ellison, Misoo C; Cheng, Jonathan D; Chirovsky, Diana Romana; Swaby, Ramona F; Cohen, Ezra E W Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 2(2021) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Real‐world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno‐oncology therapy. Issue 8 (9th March 2020) Authors: Mehra, Ranee; Huang, Huan; Seal, Brian; Tse, Jenny; Shenolikar, Rahul A.; Burudpakdee, Chakkarin Journal: Head & neck Issue: Volume 42:Issue 8(2020) Page Start: 2030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Regionalization of Head and Neck Oncology Tumor Boards: Perspectives of Collaborating Physicians. Issue 1 (28th February 2023) Authors: Amin, Neha B.; Bridgham, Kelly M.; Brown, Jessica P.; Moyer, Kelly F.; Taylor, Rodney J.; Wolf, Jeffrey S.; Witek, Matthew E.; Molitoris, Jason K.; Mehra, Ranee; Cullen, Kevin J.; Papadimitriou, John C.; Raghavan, Prashant; Hatten, Kyle M. Journal: OTO open Issue: Volume 7:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗